GX-19
- Generic Name
- GX-19
Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04915989
- Locations
- 🇰🇷
Gangnam Severance hospital, Seoul, Korea, Republic of
🇰🇷Severance hospital, Seoul, Korea, Republic of
Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults
- First Posted Date
- 2021-01-20
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 170
- Registration Number
- NCT04715997
- Locations
- 🇰🇷
KyungHee University Medical Center, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
🇰🇷Hanyang University Hospital, Seoul, Korea, Republic of
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Genexine, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04445389
- Locations
- 🇰🇷
Severance hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath